To access the conference call, please dial 844-469-2530 (U.S.) or 765-507-2679 (international), passcode #51269170. The conference call will also be broadcast live over the Internet with an accompanying slide presentation, which can be accessed on the company’s website at http://investors.materialise.com.

A replay of the conference call will be available via telephone beginning approximately one hour after the call ends through Friday, August 12, 2016. U.S. participants can access the replay by dialing 855-859-2056 and international participants can dial 404-537-3406. The access code for the replay is #51269170. A webcast of the conference call and slide presentation will be archived on the company's website for one year.

About Materialise

Materialise incorporates more than 25 years of 3D printing experience into a range of software solutions and 3D printing services, which Materialise seeks to form the backbone of the 3D printing industry. Materialise’s open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines one of the largest groups of software developers in the industry with one of the largest 3D printing facilities in the world. For additional information, please visit: www.materialise.com.

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, current estimates of fiscal 2016 revenues, deferred revenue from annual licenses and maintenance and Adjusted EBITDA, results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies, and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company's actual results to differ materially from our expectations, including risk factors described in the company's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission on April 28, 2016. There are a number of risks and uncertainties that could cause the company's actual results to differ materially from the forward-looking statements contained in this press release.

The company is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise, unless it has obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.

Consolidated income statements (Unaudited)
			For the three months ended 30 June									For the six month period ended 30 June
(in thousands, except EPS)			2016			2016			2015			2016			2015
			U.S.$			euros			euros			euros			euros
Revenue			30,638			27,597			24,772			54,264			48,120
Cost of sales			(12,594	)		(11,344	)		(10,445	)		(22,049	)		(20,326	)
Gross profit			18,044			16,253			14,327			32,215			27,794
						58.9	%		57.8	%		59.4	%		57.8	%
Research and development expenses			(5,285	)		(4,760	)		(4,371	)		(9,132	)		(8,878	)
Sales and marketing expenses			(10,584	)		(9,533	)		(9,620	)		(18,348	)		(18,835	)
General and administrative expenses			(5,428	)		(4,889	)		(3,747	)		(9,939	)		(7,322	)
Other operating income			1,974			1,778			2,462			3,064			4,370
Other operating expenses			-			-			(988	)		-			(1,116	)
Operating profit			(1,279	)		(1,151	)		(1,937	)		(2,140	)		(3,987	)
Financial expenses			(676	)		(609	)		(1,286	)		(1,506	)		(1,735	)
Financial income			906			816			348			979			2,269
Share in loss of joint venture			(145	)		(131	)		(63	)		(299	)		(123	)
Profit (loss) before taxes			(1,194	)		(1,075	)		(2,938	)		(2,966	)		(3,576	)
Income taxes			709			639			(75	)		(621	)		(325	)
Net profit (loss)			(485	)		(436	)		(3,013	)		(3,587	)		(3,901	)
Net profit (loss) attributable to:
The owners of the parent			(485	)		(436	)		(3,013	)		(3,587	)		(3,848	)
Non-controlling interest			-			-			-			-			(53	)
Earnings per share attributable to
ordinary owners of the parent
Basic			(0.01	)		(0.01	)		(0.06	)		(0.08	)		(0.08	)
Diluted			(0.01	)		(0.01	)		(0.06	)		(0.08	)		(0.08	)
Weighted average basic			47,325			47,325			47,227			47,325			47,199
Weighted average with effect dilution			47,325			47,325			47,227			47,325			47,199

Consolidated statements of comprehensive income (Unaudited)
(in thousands, except EPS)
			For the three months ended 30 June									For the six month period ended 30 June
			2016			2016			2015			2016			2015
			U.S.$			euros			euros			euros			euros
Net profit (loss) for the period			(485	)		(436	)		(3,013	)		(3,587	)		(3,901	)
Other comprehensive income (loss)
Exchange differences on translation of foreign operations			(527	)		(475	)		163			(1,439	)		1,476
Other comprehensive income (loss), net of taxes			(527	)		(475	)		163			(1,439	)		1,476
Total comprehensive income (loss) for the period, net of taxes			(1,012	)		(911	)		(2,850	)		(5,026	)		(2,425	)
Total comprehensive income (loss) attributable to:
The owners of the parent			(1,012	)		(911	)		(2,850	)		(5,026	)		(2,372	)
Non-controlling interest			-			-			-			-			(53	)

Consolidated statements of financial position (Unaudited)
		30 June			31 December
(in thousand euros)		2016			2015
Assets
Non-current assets
Goodwill		9,023			9,664
Intangible assets		8,801			9,657
Property, plant & equipment		41,180			38,400
Investments in joint ventures		719			1,018
Deferred tax assets		531			1,092
Other financial assets		339			356
Total non-current assets		60,593			60,187
Current assets
Inventory		5,392			5,387
Trade receivables		20,547			22,843
Tax receivables
Held to maturity investments		-			-
Other current assets		5,421			4,993
Cash and cash equivalents		51,304			50,726
Total current assets		82,664			83,949
Total assets		143,257			144,136
Equity and liabilities
Equity
Share capital		2,729			2,729
Share premium		78,411			78,098
Consolidated reserves		(2,175	)		1,407
Treasury shares					-
Other comprehensive income		(718	)		721
Equity attributable to the owners of the parent		78,247			82,955
Non-controlling interest		-			-
Total equity		78,247			82,955
Non-current liabilities
Loans & borrowings		18,197			16,607
Deferred tax liabilities		1,348			2,068
Deferred income		29			92
Other non-current liabilities		2,349			2,244
Total non-current liabilities		21,923			21,011
Current liabilities
Loans & borrowings		4,520			4,482
Trade payables		9,413			9,712
Tax payables		492			255
Deferred income		18,103			16,509
Other current liabilities		10,559			9,212
Total current liabilities		43,087			40,170
Total equity and liabilities		143,257			144,136

Consolidated cash flow statements (Unaudited)
(in thousand euros)		For the six month period ended 30 June
		2016			2015
		euros			euros
Operating activities
Net profit for the period		(3,587	)		(3,901	)
Non-cash and operational adjustments
Depreciation of property, plant & equipment		3,012			2,373
Amortization of intangible assets		938			678
Share-based payment expense		360			472
Loss (gain) on disposal of property, plant & equipment		(62	)		(54	)
Fair value adjustment contingent liabilities		54			-
Movement in provisions and allowance for bad debt		111			101
Financial income		(87	)		(211	)
Financial expense		483			498
Impact of foreign currencies		131			(1,153	)
Share of loss / (profit) of an associate or joint venture (equity method)		299			123
Deferred tax expense (income)		(159	)		(81	)
Income taxes		781			406
Other		(40	)		(4	)
Working capital adjustments
Increase in trade receivables and other receivables		1,654			(1,943	)
Decrease (Increase) in inventories		(5	)		(879	)
Increase in trade payables and other payables		2,442			5,274
Income tax paid		(544	)		(338	)
Net cash flow from operating activities		5,781			1,361
Investing activities
Purchase of property, plant & equipment		(5,831	)		(3,558	)
Purchase of intangible assets		(526	)		(674	)
Proceeds from the sale of property, plant & equipment, net		708			139
Proceeds from the sale of intangibles		19			-
Acquisition of subsidiary		-			(1,602	)
Investments in joint-ventures		-			(500	)
Proceeds from held to maturity investments		-			10,000
Interest received		6			7
Net cash flow used in investing activities		(5,624	)		3,812
Financing activities
Proceeds from loans & borrowings and convertible debt		2,812			319
Repayment of loans & borrowings		(1,346	)		(3,410	)
Repayment of finance leases		(843	)		(731	)
Purchase of non-controlling interest		-			(1,377	)
Capital increase in parent company		-			580
Interest paid		(328	)		(252	)
Other financial income / (expense)		(32	)		14
Net cash flow from financing activities		263			(4,857	)
Net increase of cash and cash equivalents		420			316
Cash and cash equivalents at beginning of period		50,726			51,019
Exchange rate differences on cash & cash equivalents		158			1,364
Cash & cash equivalents at end of period		51,304			52,699

Segment P&L (Unaudited)
	In thousands euros		Materialise Software			Materialise Medical			Materialise Manufacturing			Total segments			Adjustments & eliminations			Consolidated
	For the three month period ended 30 June 2016
	Revenues		6,981			9,706			10,907			27,594			3			27,597
	Segment EBITDA		1,602			14			430			2,046			(1,157	)		889
	Segment EBITDA %		22.9	%		0.1	%		3.9	%		7.4	%					3.2	%
	For the three month period ended 30 June 2015
	Revenues		6,078			8,315			10,379			24,772			-			24,772
	Segment EBITDA		2,015			(342	)		(147	)		1,526			(1,957	)		(431	)
	Segment EBITDA %		33.2	%		-4.1	%		-1.4	%		6.2	%					-1.7	%
	For the six month period ended 30 June 2016
	Revenues		14,412			18,312			21,513			54,237			27			54,264
	Segment EBITDA		4,367			(516	)		687			4,538			(2,728	)		1,810
	Segment EBITDA %		30.3	%		-2.8	%		3.2	%		8.4	%					3.3	%
	For the six month period ended 30 June 2015
	Revenues		12,194			16,163			19,763			48,120			-			48,120
	Segment EBITDA		4,230			(1,088	)		(187	)		2,955			(3,894	)		(939	)
	Segment EBITDA %		34.7	%		-6.7	%		-0.9	%		6.1	%					-2.0	%

Reconciliation of Net Profit/(Loss) to EBITDA and Adjusted EBITDA (Unaudited)
(in thousands)		For the three months ended 30 June
		2016			2015
		euros			euros
Net profit / (loss)		(436	)		(3,013	)
Income taxes		(639	)		75
Financial expenses		609			1,286
Financial income		(816	)		(348	)
Share in loss of a joint venture		131			63
Depreciation & amortization		2,040			1506
EBITDA		889			(431	)
Non-cash stock-based compensation expenses (1)		145			252
Adjusted EBITDA		1,034			(179	)

(1)		Non-cash stock-based compensation expenses represent the cost of equity-settled and cash-settled share-based payments to employees.

« Previous Page 1 | 2 | 3 | 4  Next Page »